<p>p-value<sup>1</sup>: comparison of clinical features in IgM-secreting and non-secreting DLBCL subgroups.</p><p>p-value<sup>2</sup> comparison of clinical features in IgM-secreting and IgM+/non-secreting DLBCL subgroups.</p><p>ALC<sup>3</sup>: absolute lymphocyte count.</p><p>COO<sup>4</sup>:: cell of origin based on the Hans algorithm.</p><p>CNS<sup>5</sup> central nervous system involvement at diagnosis or relapse.</p><p>ECOG-PS<sup>6</sup>≥2: performance status following the ECOG nomenclature.</p><p>IPI 3–5<sup>7</sup>: International prognostic index score 3–5.</p
<p>Results expressed as number of B-cell clones and percentage between brackets or as *median value ...
Diffuse large B-cell lymphoma (DLBCL) is the most common type of high-grade B-cell lymphoma with dif...
Background: CD10, BCL6, and MUM1 are commonly used immunohistochemical stains for classifying diffus...
<p><sup>@</sup>IPI & Stage information was available only in 89 patients. ?GC vs. ABC Germinal Centr...
<p>CNS<sup>1</sup>: Central nervous system involvement at diagnosis or during relapse progression.</...
Background. The development of gene expression profiling and tissue microarray techniques have provi...
Background and Aim: Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lym...
<p>(A, B) OS (A) and PFS (B) of all patients treated with CHOP or R-CHOP. (C, D) OS (C) and PFS (D) ...
<p>%: number of positivity/total number of the subgroup; MC, included 3 medullary carcinomas and 3 m...
PURPOSE: Whether diffuse large B-cell lymphoma (DLBCL) of primary central nervous system origin (PCN...
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease identified by morphology, immunophe...
large B-cell lymphoma (DLBCL) is a variant of DLBCL, expressing the ALK kinase (Delsol et al., 2008)...
Item does not contain fulltextPURPOSE: The results of immunohistochemical class prediction and progn...
<p>a) PFS of IgM-secreting and non-secreting DLBCL patients; b) PFS of IgM-secreting and non-GCB-typ...
<p><i>P</i> values were derived from Pearson’s Chi-Square test. Bold font indicates significance. UL...
<p>Results expressed as number of B-cell clones and percentage between brackets or as *median value ...
Diffuse large B-cell lymphoma (DLBCL) is the most common type of high-grade B-cell lymphoma with dif...
Background: CD10, BCL6, and MUM1 are commonly used immunohistochemical stains for classifying diffus...
<p><sup>@</sup>IPI & Stage information was available only in 89 patients. ?GC vs. ABC Germinal Centr...
<p>CNS<sup>1</sup>: Central nervous system involvement at diagnosis or during relapse progression.</...
Background. The development of gene expression profiling and tissue microarray techniques have provi...
Background and Aim: Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lym...
<p>(A, B) OS (A) and PFS (B) of all patients treated with CHOP or R-CHOP. (C, D) OS (C) and PFS (D) ...
<p>%: number of positivity/total number of the subgroup; MC, included 3 medullary carcinomas and 3 m...
PURPOSE: Whether diffuse large B-cell lymphoma (DLBCL) of primary central nervous system origin (PCN...
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease identified by morphology, immunophe...
large B-cell lymphoma (DLBCL) is a variant of DLBCL, expressing the ALK kinase (Delsol et al., 2008)...
Item does not contain fulltextPURPOSE: The results of immunohistochemical class prediction and progn...
<p>a) PFS of IgM-secreting and non-secreting DLBCL patients; b) PFS of IgM-secreting and non-GCB-typ...
<p><i>P</i> values were derived from Pearson’s Chi-Square test. Bold font indicates significance. UL...
<p>Results expressed as number of B-cell clones and percentage between brackets or as *median value ...
Diffuse large B-cell lymphoma (DLBCL) is the most common type of high-grade B-cell lymphoma with dif...
Background: CD10, BCL6, and MUM1 are commonly used immunohistochemical stains for classifying diffus...